Table 4. The ratio of CD4+ and CD8+ effector T cells in DLBCL primary tissue and peripheral blood.
GCB-DLBCL (n = 8) | ABC-DLBCL (n = 12) | EBV+DLBCL (n = 7) | Healthy control (n = 15) | ||||
---|---|---|---|---|---|---|---|
LN | PB | LN | PB | LN | PB | PB | |
CD4 Tem/CD4+T(%) | 61.20±6.13*** | 32.30±5.15 | 63.91±13.20*** | 35.71±8.19 | 71.73±15.12*** | 43.00±7.41 | 23.31±4.50 |
CD8 Tem/CD8+T(%) | 65.20±8.14*** | 36.50±9.15 | 68.22±12.00*** | 39.69±6.79 | 79.17±11.89*** | 44.30±7.83 | 28.40±6.78 |
Note: LN: lymph node, PB: peripheral blood, DLBCL: diffuse large B-cell lymphoma, Tem: effector T cells
***P<0.001